Microbial Products Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Microbial Products Market: by Type (Enzymes, Polysaccharides, Nutrients, Chemotherapeutic Agents, Antibiotics, Others), by Source (Bacterial, Viral, Fungi, Others), by Application (Pharmaceutical, Diagnostic, Biotechnology, Others), by End User (Pharmaceutical and Biotechnological Industries, Hospitals and Clinics, Diagnostic Labs, Research and Academics, Others) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Microbial Products Market size is valued at USD 190.2 billion in 2021 and is expected to reach a value of USD 343.3 billion by 2028, growing at a CAGR of 8.8% during the forecast year 2022 to 2028. The global market provides a detailed overview  and that can be segmented by type, source, application, and end-user. By type, the microbial product market has been segmented into enzymes, polysaccharides, nutrients, chemotherapeutic agents, antibiotics, and others. The enzymes segment is likely to be the largest and fastest-growing segment in terms of type. Further, nutrients are further segmented into amino acids, nucleotides, vitamins, organic acids, and others. Based on the source, the microbial products market is segmented into bacterial, viral, fungi and others. Among these, the bacterial segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on end user, the market is segmented into pharmaceutical and biotechnological industries, hospitals and clinics, diagnostic labs, research and academics and others. The pharmaceutical and biotechnological industries segment accounts for the largest share in 2021. The hospitals and clinics segment has the second-largest share during the forecast period 2021-2028.

Key Developments:

In April 2020, Sumitomo Chemicals invested USD 30 million in a joint venture with Conagen, a US-based biotechnology company.

Microbial Products Market

MARKET SUMMARY
-
8.8% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 8.8%
  • Largest Market– Asia-Pacific
  • Fastest Growing Market– North-America

Microbial Products Market

  • The Microbial Products Market report gives historical, current, and future market sizes (US$ Mn) based on by type, by application, source, end user and regions.
  • The Microbial Products Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Amgen Inc.
  • Sanofi S.A
  • Novartis AG
  • Merck & Co. Inc.
  • Valent BioSciences Corp.
Microbial Products Market Growth

Over the anticipated years, the market is expected to benefit from the rising demand for healthcare nutrients such as vitamins, as well as the rising need for diagnostic microbiological goods. The production of enzymes for end-use industries such as food preservation, leather, and paper is expected to fuel market expansion over the forecast period.


North-America Got Significant Share

Microbial Products Market

By region, the North America microbial products market is expected to witness the highest market share during the forecast period It is attributed to favorable insurance penetration, excellent reimbursement policies, and massive healthcare expenditure in this region as the cause.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The microbial products market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The microbial products market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The microbial products market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The microbial products market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The microbial products market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Microbial Products Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The microbial products market is projected to expand at a CAGR of 8.8% during the forecast period.

The major players in the global microbial products market are Kyowa Hakko Bio Co., GlaxoSmithKline plc, NovaDigm Therapeutics, Sanofi S.A, Novartis AG, Merck & Co. Inc., Valent BioSciences Corp., Amgen Inc., Pfizer Inc. Ltd, Biomérieux SA, Ajinomoto Co. Inc., and Locus FS.

Asia-Pacific is the fastest-growing region for microbial products market


Report

Table Of Content

1. Executive Summary
2. Global Microbial Products Market Introduction
2.1. Global Microbial Products Market – Taxonomy
2.2. Global Microbial Products Market –Definitions
2.2.1. Type
2.2.2. Source
2.2.3. Application
2.2.4. End User
3. Global Microbial Products Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Microbial Products Market Dynamic Factors – Impact Analysis
3.6. Global Microbial Products Market – Competition Landscape
4. Global Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Microbial Products Market, By Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Enzymes
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Polysaccharides
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Nutrients
5.3.1. Amino Acids
5.3.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.1.3. Market Opportunity Analysis
5.3.2. Nucleotides
5.3.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.2.3. Market Opportunity Analysis
5.3.3. Vitamins
5.3.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3.3. Market Opportunity Analysis
5.3.4. Organic Acids
5.3.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.4.3. Market Opportunity Analysis
5.3.5. Others
5.3.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.5.3. Market Opportunity Analysis
5.4. Chemotherapeutic Agents
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Antibiotics
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Global Microbial Products Market Forecast, By Source, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
6.1. Bacterial
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Viral
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Fungi
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Microbial Products Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
7.1. Pharmaceutical
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Diagnostic
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Biotechnology
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Microbial Products Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnological Industries
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals and Clinics
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Diagnostic Labs
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Research and Academics
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Global Microbial Products Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
9.1. North America
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Region, 2022 – 2028
10. North America Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
10.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Enzymes
10.1.2. Polysaccharides
10.1.3. Nutrients
10.1.3.1. Amino Acids
10.1.3.2. Nucleotides
10.1.3.3. Vitamins
10.1.3.4. Organic Acids
10.1.3.5. Others
10.1.4. Chemotherapeutic Agents
10.1.5. Antibiotics
10.1.6. Others
10.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Bacterial
10.2.2. Viral
10.2.3. Fungi
10.2.4. Others
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Pharmaceutical
10.3.2. Diagnostic
10.3.3. Biotechnology
10.3.4. Others
10.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnological Industries
10.4.2. Hospitals and Clinics
10.4.3. Diagnostic Labs
10.4.4. Research and Academics
10.4.5. Others
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028
10.7. North America Microbial Products Market Dynamics – Trends
11. Europe Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
11.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Enzymes
11.1.2. Polysaccharides
11.1.3. Nutrients
11.1.3.1. Amino Acids
11.1.3.2. Nucleotides
11.1.3.3. Vitamins
11.1.3.4. Organic Acids
11.1.3.5. Others
11.1.4. Chemotherapeutic Agents
11.1.5. Antibiotics
11.1.6. Others
11.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Bacterial
11.2.2. Viral
11.2.3. Fungi
11.2.4. Others
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Pharmaceutical
11.3.2. Diagnostic
11.3.3. Biotechnology
11.3.4. Others
11.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnological Industries
11.4.2. Hospitals and Clinics
11.4.3. Diagnostic Labs
11.4.4. Research and Academics
11.4.5. Others
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028
11.7. Europe Microbial Products Market Dynamics – Trends
12. Asia-Pacific Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
12.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Enzymes
12.1.2. Polysaccharides
12.1.3. Nutrients
12.1.3.1. Amino Acids
12.1.3.2. Nucleotides
12.1.3.3. Vitamins
12.1.3.4. Organic Acids
12.1.3.5. Others
12.1.4. Chemotherapeutic Agents
12.1.5. Antibiotics
12.1.6. Others
12.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Bacterial
12.2.2. Viral
12.2.3. Fungi
12.2.4. Others
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Pharmaceutical
12.3.2. Diagnostic
12.3.3. Biotechnology
12.3.4. Others
12.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnological Industries
12.4.2. Hospitals and Clinics
12.4.3. Diagnostic Labs
12.4.4. Research and Academics
12.4.5. Others
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028
12.7. Asia-Pacific Microbial Products Market Dynamics – Trends
13. Latin America Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
13.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Enzymes
13.1.2. Polysaccharides
13.1.3. Nutrients
13.1.3.1. Amino Acids
13.1.3.2. Nucleotides
13.1.3.3. Vitamins
13.1.3.4. Organic Acids
13.1.3.5. Others
13.1.4. Chemotherapeutic Agents
13.1.5. Antibiotics
13.1.6. Others
13.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Bacterial
13.2.2. Viral
13.2.3. Fungi
13.2.4. Others
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Pharmaceutical
13.3.2. Diagnostic
13.3.3. Biotechnology
13.3.4. Others
13.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnological Industries
13.4.2. Hospitals and Clinics
13.4.3. Diagnostic Labs
13.4.4. Research and Academics
13.4.5. Others
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Rest of Latin America
13.6. Latin America Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028
13.7. Latin America Microbial Products Market Dynamics – Trends
14. Middle East and Africa Microbial Products Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) 
14.1. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Enzymes
14.1.2. Polysaccharides
14.1.3. Nutrients
14.1.3.1. Amino Acids
14.1.3.2. Nucleotides
14.1.3.3. Vitamins
14.1.3.4. Organic Acids
14.1.3.5. Others
14.1.4. Chemotherapeutic Agents
14.1.5. Antibiotics
14.1.6. Others
14.2. Source Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Bacterial
14.2.2. Viral
14.2.3. Fungi
14.2.4. Others
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Pharmaceutical
14.3.2. Diagnostic
14.3.3. Biotechnology
14.3.4. Others
14.4. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnological Industries
14.4.2. Hospitals and Clinics
14.4.3. Diagnostic Labs
14.4.4. Research and Academics
14.4.5. Others
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Microbial Products Market – Opportunity Analysis Index, By Type, Source, Application, End User and Country, 2022 – 2028
14.7. MEA Microbial Products Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Kyowa Hakko Bio Co.
15.2.2. GlaxoSmithKline plc
15.2.3. NovaDigm Therapeutics
15.2.4. Sanofi S.A
15.2.5. Novartis AG
15.2.6. Merck & Co. Inc.
15.2.7. Valent BioSciences Corp.
15.2.8. Amgen Inc.
15.2.9. Pfizer Inc. Ltd
15.2.10. Biomérieux SA
15.2.11. Ajinomoto Co. Inc.
15.2.12. Locus FS
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Kyowa Hakko Bio Co.
  • GlaxoSmithKline plc
  • NovaDigm Therapeutics
  • Sanofi S.A
  • Novartis AG
  • Merck & Co. Inc.
  • Valent BioSciences Corp.
  • Amgen Inc.
  • Pfizer Inc. Ltd
  • Biomérieux SA
  • Ajinomoto Co. Inc.
  • Locus FS

Description

Microbial Products Market size is valued at USD 190.2 billion in 2021 and is expected to reach a value of USD 343.3 billion by 2028, growing at a CAGR of 8.8% during the forecast year 2022 to 2028. The global market provides a detailed overview  and that can be segmented by type, source, application, and end-user. By type, the microbial product market has been segmented into enzymes, polysaccharides, nutrients, chemotherapeutic agents, antibiotics, and others. The enzymes segment is likely to be the largest and fastest-growing segment in terms of type. Further, nutrients are further segmented into amino acids, nucleotides, vitamins, organic acids, and others. Based on the source, the microbial products market is segmented into bacterial, viral, fungi and others. Among these, the bacterial segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on end user, the market is segmented into pharmaceutical and biotechnological industries, hospitals and clinics, diagnostic labs, research and academics and others. The pharmaceutical and biotechnological industries segment accounts for the largest share in 2021. The hospitals and clinics segment has the second-largest share during the forecast period 2021-2028.

Key Developments:

In April 2020, Sumitomo Chemicals invested USD 30 million in a joint venture with Conagen, a US-based biotechnology company.

Reviews

There are no reviews yet.

Be the first to review “Microbial Products Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX